Canakinumab Subcutaneous and Rexaphenac
Determining the interaction of Canakinumab Subcutaneous and Rexaphenac and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: diclofenac topical
Brand name: DST Plus Pak, Pennsaid, Solaraze, Voltaren Topical, Diclozor, Voltaren, Flector Patch, Klofensaid II, Vopac MDS, Xrylix, Flector, Licart
Synonyms: Diclofenac topical, Diclofenac (Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Rexulti
- Canakinumab Subcutaneous-Reyataz
- Canakinumab Subcutaneous-Reyataz (Atazanavir Capsules)
- Canakinumab Subcutaneous-Reyataz (Atazanavir Powder for Oral Suspension)
- Canakinumab Subcutaneous-Reyvow
- Canakinumab Subcutaneous-Rezira
- Rexaphenac-Canasa
- Rexaphenac-Canasa Pac rectal
- Rexaphenac-Canasa rectal
- Rexaphenac-Cancidas
- Rexaphenac-Candesartan
- Rexaphenac-Candesartan and Hydrochlorothiazide